- Home
- TOPP vs CODX Comparison
TOPP vs CODX Comparison
Compare TOPP & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- CODX
- Stock Information
- Founded
- TOPP 2014
- CODX 2013
- Country
- TOPP United States
- CODX United States
- Employees
- TOPP N/A
- CODX N/A
- Industry
- TOPP
- CODX Medical/Dental Instruments
- Sector
- TOPP
- CODX Health Care
- Exchange
- TOPP NYSE
- CODX Nasdaq
- Market Cap
- TOPP 22.4M
- CODX 22.0M
- IPO Year
- TOPP 2025
- CODX 2017
- Fundamental
- Price
- TOPP $1.22
- CODX $0.35
- Analyst Decision
- TOPP
- CODX Hold
- Analyst Count
- TOPP 0
- CODX 1
- Target Price
- TOPP N/A
- CODX $1.00
- AVG Volume (30 Days)
- TOPP 91.6K
- CODX 249.9K
- Earning Date
- TOPP 01-01-0001
- CODX 05-08-2025
- Dividend Yield
- TOPP N/A
- CODX N/A
- EPS Growth
- TOPP N/A
- CODX N/A
- EPS
- TOPP 0.01
- CODX N/A
- Revenue
- TOPP $16,039,513.00
- CODX $3,915,160.00
- Revenue This Year
- TOPP N/A
- CODX N/A
- Revenue Next Year
- TOPP N/A
- CODX N/A
- P/E Ratio
- TOPP $104.65
- CODX N/A
- Revenue Growth
- TOPP N/A
- CODX N/A
- 52 Week Low
- TOPP $1.05
- CODX $0.28
- 52 Week High
- TOPP $4.50
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- CODX 40.40
- Support Level
- TOPP N/A
- CODX $0.30
- Resistance Level
- TOPP N/A
- CODX $0.40
- Average True Range (ATR)
- TOPP 0.00
- CODX 0.06
- MACD
- TOPP 0.00
- CODX 0.01
- Stochastic Oscillator
- TOPP 0.00
- CODX 58.26
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.